Market Overview:
The global carcinoembryonic antigen related cell adhesion molecule 5 (CEACAM5) market is expected to register a CAGR of XX% during the forecast period 2018-2030. The market growth can be attributed to the increasing prevalence of cancer, rising demand for targeted therapies and growing investments in R&D. Based on type, the global CEACAM5 market is segmented into ETBX-011, Vbx-016, OSE-2101, GI-6207 and others. Based on application, the global CEACAM5 market is segmented into metastatic breast cancer, metastatic pancreatic cancer peritoneal tumor and others. Geographically, the global CEACAM5 market is segmented into North America, Latin America Europe Asia Pacific and Middle East & Africa. North America dominates the global CEACAM5 Market due to early adoption of novel technologies coupled with presence of key players in this region.
Product Definition:
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) is a protein that in humans is encoded by the CEACAM5 gene. The protein encoded by this gene is a member of the carcinoembryonic antigen family of immunoglobulin superfamily proteins. This protein functions as a receptor for E-selectin and mediates leukocyte adhesion to activated endothelium.
ETBX-011:
ETBX-011 is a novel, non-integrin cell surface molecule that binds to the intercellular adhesion molecule 1 (ICAM-1). ETBX-011 has been shown to have similar biological properties as ICAM-1. The most important property of ETBX -011 is its capacity for inducing immune tolerance in experimental autoimmune encephalitis models.
Vbx-016:
Carbinoembryonic antigen related cell adhesion molecule 5 is also known as Vbx-016 or CARM-5. It's a human chorionic gonadotropin hormone, which is produced in the placenta after birth. It's role in the body is to maintain proper fertility and pregnancy along with helping to create antibodies against yourself (self-administration).
Application Insights:
The metastatic breast cancer segment dominated the global market in terms of revenue in 2017. This is due to the increasing prevalence of the disease coupled with rising awareness about early diagnosis and effective treatment options. According to Breastcancer.org, around 1 in 8 U.S women develop invasive breast cancer as per an estimate made by the American Cancer Society (ACS). Moreover, according to data published by The National Center for Biotechnology Information (NCBI) in 2014, around 60% of all breast cancers are diagnosed at a late stage-III or above which comprises over 200 cases annually globally and over 300 cases every year since 2010 till 2014 in India alone owing to lack of effective screening methods coupled with high mortality rates associated with this disease makes it one of the major segments driving this market during future years as well.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased R&D investments by companies and government initiatives. For instance, in September 2018, Pfizer Inc. invested over USD X billion for a new research center in New York that focuses on immuno-oncology and vaccines against cancer cells migration & invasion as well as inflammation pathways. The company also established an exploratory research program with an aim to identify novel targets for cancer treatment using its own funds worth USD X million over a period of five years (2018-03).
Asia Pacific is expected to witness lucrative growth during the forecast period owing to increasing number of patients suffering from metastatic cancers which are refractory or untreatable due to their advanced stage nature coupled with rising healthcare expenditure levels in emerging countries such as China & India (USD X billion & USD X billion respectively) along with other factors such as growing medical tourism industry.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market. According to the World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths from cancer worldwide. This number is expected to increase to 21 million new cases and 13 million deaths by 2030. This will create a large demand for Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 products, which will drive the growth of the market.
- Rising awareness about early detection: There is a growing awareness among people about the importance of early detection of cancers for better treatment outcomes. This is driving them to seek diagnostic tests such as those that detect Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 levels in blood or tissues at an early stage itself, thereby fuelling demand for Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 products and services globally.
- The National Cancer Institute (NCI) in collaboration with six other institutes announced plans to invest more than 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Research Report
By Type
ETBX-011, Vbx-016, OSE-2101, GI-6207, Others
By Application
Metastatic Breast Cancer, Metastatic Pancreatic Cancer, Peritoneal Tumor, Others
By Companies
Akshaya Bio Inc., Celgene Corporation, Etubics Corporation, OSE Immunotherapeutics, Vaxon Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Report Segments:
The global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market is segmented on the basis of:
Types
ETBX-011, Vbx-016, OSE-2101, GI-6207, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Metastatic Breast Cancer, Metastatic Pancreatic Cancer, Peritoneal Tumor, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Akshaya Bio Inc.
- Celgene Corporation
- Etubics Corporation
- OSE Immunotherapeutics
- Vaxon Biotech
Highlights of The Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ETBX-011
- Vbx-016
- OSE-2101
- GI-6207
- Others
- By Application:
- Metastatic Breast Cancer
- Metastatic Pancreatic Cancer
- Peritoneal Tumor
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 is a protein that helps cells attach to each other.
Some of the major players in the carcinoembryonic antigen related cell adhesion molecule 5 market are Akshaya Bio Inc., Celgene Corporation, Etubics Corporation, OSE Immunotherapeutics, Vaxon Biotech.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size & Forecast, 2020-2028
4.5.1 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size and Y-o-Y Growth
4.5.2 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 ETBX-011
5.2.2 Vbx-016
5.2.3 OSE-2101
5.2.4 GI-6207
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Metastatic Breast Cancer
6.2.2 Metastatic Pancreatic Cancer
6.2.3 Peritoneal Tumor
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 ETBX-011
9.6.2 Vbx-016
9.6.3 OSE-2101
9.6.4 GI-6207
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Metastatic Breast Cancer
9.10.2 Metastatic Pancreatic Cancer
9.10.3 Peritoneal Tumor
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 ETBX-011
10.6.2 Vbx-016
10.6.3 OSE-2101
10.6.4 GI-6207
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Metastatic Breast Cancer
10.10.2 Metastatic Pancreatic Cancer
10.10.3 Peritoneal Tumor
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 ETBX-011
11.6.2 Vbx-016
11.6.3 OSE-2101
11.6.4 GI-6207
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Metastatic Breast Cancer
11.10.2 Metastatic Pancreatic Cancer
11.10.3 Peritoneal Tumor
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 ETBX-011
12.6.2 Vbx-016
12.6.3 OSE-2101
12.6.4 GI-6207
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Metastatic Breast Cancer
12.10.2 Metastatic Pancreatic Cancer
12.10.3 Peritoneal Tumor
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 ETBX-011
13.6.2 Vbx-016
13.6.3 OSE-2101
13.6.4 GI-6207
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Metastatic Breast Cancer
13.10.2 Metastatic Pancreatic Cancer
13.10.3 Peritoneal Tumor
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market: Competitive Dashboard
14.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Akshaya Bio Inc.
14.3.2 Celgene Corporation
14.3.3 Etubics Corporation
14.3.4 OSE Immunotherapeutics
14.3.5 Vaxon Biotech
